Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil drives awareness of Notivisa adverse events reporting programme:

This article was originally published in Clinica

Executive Summary

Brazil's healthcare products regulatory agency, Anvisa, is continuing its efforts to raise awareness of its new Notivisa healthcare vigilance and surveillance programme (see Clinica No 1198, p 13). The Brasilia-based agency hosted yesterday, in Sao Paulo city, the conference "Notivisa, a new paradigm in healthcare vigilance". Focusing specifically on the electronic reporting of adverse events and technical faults involving medical products, the meeting was addressed primarily at the medical staff and healthcare industry bodies and associations in three of the country's five regions, namely the south, southeast and centrewest.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel